Cabot Corporation (NYSE: CBT) is a leading global specialty chemical and performance materials company headquartered in Boston, Massachusetts. We deliver performance solutions that solve customers'​ challenges today and prepare them to meet tomorrow's needs.

Sumitomo Pharma America (SMPA) is a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need in psychiatry and neurology, oncology, urology, women’s health, rare disease, and cell and gene therapies. SMPA was formed through the consolidation of Sumitomo Pharma’s U.S. affiliate companies including Sunovion Pharmaceuticals, Inc., Sumitomo Pharma America Holdings, Inc., Sumitomo Pharma Oncology, Inc., Sumitovant Biopharma, Inc., Myovant Sciences, Inc., Urovant Sciences, Inc. and Enzyvant Therapeutics, Inc. SMPA is a Sumitomo Pharma company. Community Guidelines: https://www.us.sumitomo-pharma.com/social-media/index.html

About us With more than 65 years of experience in delivering life-changing science, Lantheus is committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow disease. Lantheus is headquartered in Massachusetts and has offices in New Jersey, Canada and Sweden.

LGC is a leading, global life science tools company, providing mission-critical components and solutions into high-growth application areas across the human healthcare and applied market segments. Its high quality product portfolio is comprised of mission-critical tools for genomic analysis and for quality assurance applications, which are typically embedded and recurring within our customers’ products and workflows and are valued for their performance, quality and range. LGC’s tools play a key role in customer workflows from discovery applications through to commercial manufacture and enable its customers to: bring new diagnostics and therapies to market; progress research and development; optimise food production; and continuously monitor and enhance the quality of food, the environment and consumer products. LGC’s 175+ years of scientific heritage, combined with a track record of innovation and value-enhancing acquisitions, has enabled the company to build its product portfolio and expertise, and develop deep relationships with customers, industry partners and the global scientific community. LGC’s core purpose of Science for a safer world and its core values of passion, curiosity, integrity, brilliance and respect, drive its culture. As of 30 June 2021, it employs 4,350 employees, of which over 1,175 employees hold PhD and/or master’s degrees. Its products and services are delivered by highly qualified and experienced teams, operating from a global network of accredited sites that showcase its scientific and manufacturing capabilities.

Cambridge Isotope Laboratories, Inc. (CIL) is the world leader in the separation and manufacture of stable isotopes and stable isotope-labeled compounds. With approximately 700 employees and laboratories in five countries, CIL specializes in the process of labeling biochemical and organic compounds with highly enriched, stable (non-radioactive) isotopes of carbon, hydrogen, nitrogen and oxygen. Our chemists substitute a common atom for a rare, highly valued isotopic component so that the final product can be readily measured or traced using mass spectrometry (mass spec) or nuclear magnetic resonance (NMR). CIL¹s products are utilized in laboratories, medical, government and academic research centers and health care facilities worldwide. We are proud that CIL products have contributed to medical advancements in cancer research, new drug development, environmental analysis, genomics and proteomics and medical diagnostic research. CIL¹s vision began when it was founded in 1981 by Dr. Joel Bradley, an organic chemist from MIT. We now produce more than 15,000 products and have ISO 13485 quality systems, as well as cGMP production capabilities. The CIL group is comprised of six companies: Cambridge Isotope Laboratories, Inc. (CIL), CIL Isotope Separations (CIS), CIL Canada, Inc. in Montreal, Canada; Euriso-Top in Saclay, France; ABX GmbH in Dresden, Germany and CIL China.

ICP Building Solutions is the foremost supplier of professional products and solutions for building envelope, cementitious and sports surface needs. Comprising dozens of industry-leading brands across numerous industries and applications, ICP offers the industry’s most comprehensive portfolios to building professionals all over the globe, all backed by its exclusive Masterworks training and education program.

At Worthen Industries we specialize in sustainable solutions by applying technology and a customer-first approach to every challenge. The result isn’t just an industry-leading product. It’s a solution that ensures your processes, product quality, efficiency and environmental practices are optimized. We believe the future is worth doing right.

Responsible for process and automation engineering at OXB Solutions.

Maplight is a biopharmaceutical company discovering and developing novel therapeutics for patients with disorders of the central nervous system (CNS).

Xtalic creates performance breakthroughs using our proprietary Dynamic Nanostructure Control® to custom tailor unique Nanostructured metal alloys to deliver new levels of performance, reduce use of high cost raw materials and replace toxic or unsafe materials.

Chemtan company Inc. is a chemicals company based out of United States.

At ChemGenes, we redefine the limits of scientific discovery, development and commercialization by manufacturing the broadest range of modified chemistries available in today’s market. We produce building blocks of life used by scientists and physicians in academic institutions, as well as pharmaceutical and biotechnology companies around the globe, to accelerate breakthroughs, spark innovation and develop lifesaving diagnostics and medicines. Established in 1981, ChemGenes is the world’s most experienced DNA and RNA manufacturing company. As a trailblazer in nucleic acid research and synthesis for nearly half a century, ChemGenes has earned its position as a market leader in the field of nucleic acid chemistry. With our state-of-the-art manufacturing facility located just North of Boston, ChemGenes is customer centric, nimble and well positioned to scale alongside our partners. We’ve helped manufacturers introduce vital new medicines and – in an achievement with truly global implications – manufactured critical materials used in lifesaving COVID-19 vaccines and diagnostics. But beyond even these accomplishments, what sets us apart is our compassionate approach toward our customers, vendors and employees. We are a potent force for good, a close-knit and supportive team whose commitment to science, innovation and discovery is matched by – perhaps even exceeded by – our passion for helping people and changing lives for the better.